Metabolep Fundación Luzón Fundación La Caixa Does the metabolism hide
the solution to treat ALS

Metabolep inicio

METABOLEP

A potential metabolic - targeted therapeutic for Amyotrophic lateral sclerosis (ALS): Leptin

METABOLEP is an international research and innovative project funded by the prestigious HEALTH RESEARCH from “la Caixa” Foundation in collaboration with Fundacion Francisco Luzon.

INSTITUTES

The Metabolep consortium is composed of…

The service from discovery intensive for search ensues to find drives accelerated by delivery of preclinical candidate.

The service from discovery intensive for search ensues to find drives accelerated by delivery of preclinical candidate.

About Us

Our Vission and Mission

METABOLEP will aim to develop a relevant dietary intervention with the goal of increasing plasma levels of the adipocytokine leptin, to reduce hypermetabolism in ALS, through integrating studies in human tissue and animal models of emerging metabolism-centric therapeutic avenues for this disease.

Metabolep

Latest news

Laboratory of Neurometabolism at Hospital Nacional de Parapléjicos (SESCAM)